Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.38 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21756941 | 0.93 | MAPT (0.45) | CYP2C9CYP1A2CYP2C19CYP2D6MAPT | |
| SCHEMBL12220514 | 0.86 | ESR2 (0.42) | ESR2CYP2C9CYP1A2CYP2C19CYP2D6 | |
| SCHEMBL5682640 | 0.85 | HAO1 (0.43) | CYP2C9CYP1A2CYP2C19CYP2D6MAPT | |
| SCHEMBL10033588 | 0.83 | SMN1; SMN2 (0.38) | CYP2C9CYP1A2CYP2C19CYP2D6MAPT | |
| SCHEMBL21765332 | 0.83 | MAPT (0.45) | CYP2C9CYP1A2CYP2C19CYP2D6MAPT | |
| SCHEMBL17722779 | 0.82 | MAPT (0.37) | CYP2C9CYP1A2CYP2C19CYP2D6MAPT | |
| SCHEMBL17720303 | 0.82 | ESR2 (0.40) | ESR2CYP2C9CYP1A2CYP2C19CYP2D6 | |
| SCHEMBL10017553 | 0.82 | SLC6A4 (0.41) | CYP2C9CYP1A2CYP2C19CYP2D6MAPT | |
| SCHEMBL13910064 | 0.80 | SLC6A2 (0.40) | CYP2C9CYP1A2CYP2C19CYP2D6MAPT | |
| SCHEMBL16171980 | 0.80 | CYP2C9 (0.47) | ESR2CYP2C9CYP1A2CYP2C19CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9523889-B2 | Liquid crystal display unit and method of manufacturing the same | SONY CORPORATION (JP) | 2016-12-20 | — | — | US | disclosed |
| US-9507210-B2 | Liquid crystal display and method of manufacturing the same | SONY CORPORATION (JP) | 2016-11-29 | — | — | US | disclosed |
| US-9470929-B2 | Liquid crystal display unit and method of manufacturing the same | SONY CORPORATION (JP) | 2016-10-18 | — | — | US | disclosed |
| US-9366910-B2 | Liquid crystal display and method of manufacturing the same | SONY CORPORATION (JP) | 2016-06-14 | — | — | US | disclosed |
| US-20160011463-A1 | LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2016-01-14 | — | — | US | disclosed |
| US-9146425-B2 | Liquid crystal display and method of manufacturing the same | SONY CORPORATION (JP) | 2015-09-29 | — | — | US | disclosed |
| US-20150146148-A1 | LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2015-05-28 | — | — | US | disclosed |
| US-20140170926-A1 | LIQUID CRYSTAL DISPLAY AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2014-06-19 | — | — | US | disclosed |
| US-20130155360-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2013-06-20 | — | — | US | disclosed |
| US-20130010244-A1 | LIQUID CRYSTAL DISPLAY AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION | 2013-01-10 | — | — | US | disclosed |
| US-20120212697-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF | SONY CORPORATION (JP) | 2012-08-23 | — | — | US | disclosed |
| US-20120026440-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND METHOD FOR MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2012-02-02 | — | — | US | disclosed |
| US-20110273652-A1 | LIQUID CRYSTAL DISPLAY AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2011-11-10 | — | — | US | disclosed |
| US-20110157531-A1 | LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2011-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160011463-A1 | LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME | PYM1, PDCD2L, SDAD1 | ESR2 4689/4885CYP2C9 3211/4885CYP1A2 3787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.